The objective of the Alzheimers Disease Prevention Trials initiative is to enable the testing of promising pharmacological and non-pharmacological interventions in asymptomatic at-risk individuals and/or individuals with Mild Cognitive Impairment (MCI) and in doing so identify avenues for prevention of Alzheimers disease (AD).
Funding Number:
RFA-AG-13-015
Office:
DN [2]
Expiration Date:
Tuesday, January 15, 2013
Release Date:
Monday, October 15, 2012